Missouri Trust & Investment Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$100K Buy
285
+4
+1% +$1.43K 0.03% 177
2025
Q4
$92K Hold
281
0.03% 176
2025
Q3
$79.3K Hold
281
0.02% 182
2025
Q2
$78.5K Sell
281
-26
-8% -$7.37K 0.03% 177
2025
Q1
$95.6K Buy
307
+43
+16% +$12.7K 0.03% 160
2024
Q4
$68.8K Buy
264
+27
+11% +$8.01K 0.02% 188
2024
Q3
$76.4K Hold
237
0.03% 181
2024
Q2
$74.1K Hold
237
0.03% 170
2024
Q1
$67.4K Hold
237
0.03% 184
2023
Q4
$68.3K Buy
237
+12
+5% +$3.27K 0.03% 176
2023
Q3
$60.5K Hold
225
0.03% 171
2023
Q2
$50K Hold
225
0.03% 190
2023
Q1
$54.4K Hold
225
0.04% 158
2022
Q4
$59K Hold
225
0.04% 163
2022
Q3
$51K Hold
225
0.03% 170
2022
Q2
$55K Hold
225
0.04% 168
2022
Q1
$54K Sell
225
-10
-4% -$2.3K 0.03% 180
2021
Q4
$53K Buy
+235
New +$49.6K 0.03% 187

Other funds holding AMGN

Missouri Trust & Investment Company's AMGN Position: Q1 2026 in Review

Missouri Trust & Investment Company increased its Amgen (AMGN) stake by 1.4% in Q1 2026, buying an estimated $1.43K and bringing the position to 285 shares worth $100K. The position accounts for 0.03% of the portfolio, ranked #177.

Missouri Trust & Investment Company first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Missouri Trust & Investment Company held 285 shares of Amgen worth $100K as of Q1 2026.
  • Missouri Trust & Investment Company bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.03% of Missouri Trust & Investment Company's portfolio in Q1 2026, its #177 holding.
  • Missouri Trust & Investment Company first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.